StemCells, Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration
June 21, 2012 - (StemCells, Inc.) - "StemCells, Inc. today announced initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in dry age-related macular degeneration (AMD) referred to as Geographic Atrophy. There are no approved treatments for dry AMD." Read Full Article
